Cite
APA Citation
Loi, S., Schmid, P., Aktan, G., Karantza, V., & Salgado, R. (n.d.). 4ORelationship between tumor infiltrating lymphocytes (TILs) and response to pembrolizumab (pembro)+chemotherapy (CT) as neoadjuvant treatment (NAT) for triple-negative breast cancer (TNBC): Phase Ib KEYNOTE-173 trial. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100092361987.0x000032